Sign Up For Updates

RWC E-Live CME 2026

An aging global population, combined with increasing prevalence of non-communicable diseases such as diabetes, has led to rising numbers of patients presenting with retinal diseases including wet AMD, DME, and DR. While anti-VEGF therapies are safe and effective, they remain among the most expensive drugs covered by Medicare and other health agencies, creating financial and access challenges for patients. The introduction of biosimilars presents opportunities to reduce economic burden while maintaining clinical effectiveness; however, uncertainty remains regarding appropriate integration into clinical practice. Practice gaps exist in decision-making around initiation, continuation, switching, and monitoring of biosimilar versus branded anti-VEGF therapies. This activity addresses these gaps by providing case-based education to support evidence-informed, patient-centered treatment decisions.

To Biosimilar or Not to Biosimilar

View Details

CME Learning Objectives

After participating in this activity, learners will be able to:

  1. Evaluate clinical evidence supporting the use of biosimilar and branded anti-VEGF therapies in wet AMD, DME, and DR.
  2. Differentiate patient scenarios in which biosimilars may be appropriate versus when branded anti-VEGF therapies are warranted.
  3. Apply patient-centered and health-economic considerations when selecting and adjusting anti-VEGF treatment strategies.
  4. Implement appropriate monitoring and switching strategies based on clinical response and individual patient factors.

Target Audience

This activity is suitable for Physicians and other healthcare professionals involved in ophthalmic care.

The primary audience includes U.S.-based retina specialists managing patients with wet AMD, diabetic macular edema, and diabetic retinopathy in clinical practice. The program supports both live participants and additional learners accessing the enduring recording.

Disclosure Declaration

It is the policy of Pinnacle Conference, LLC, to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of the CE activity. Pinnacle Conference, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based date/research, and a multidisciplinary peer review process. See Activity Detail Page for Faculty Disclosures.

The content, views, and opinions expressed in this presentation are solely those of the authors and are not affiliated with, endorsed by, or representative of the Retina World Congress

Accreditation Information

This activity is supported by an independent medical education grant from Harrow Eye, LLC.

Pinnacle Conference, LLC Contact Information

For information about the accreditation of this program, please contact Hope Timmons at Pinnacle Conference, LLC at ce@learnatpinnacle.com.

Instructions for Obtaining Credit

To receive credit, participants must complete the evaluation. Upon completion, participants will be able to download or email their certificate.

Unlabeled Use Disclosure

Faculty of the CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. Pinnacle Conference, LLC, the faculty, planners, and Med Minerva, LLC do not endorse the use of any product outside of the FDA-labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Jointly Accredited Provider


In support of improving patient care, this activity has been planned and implemented by Med Minerva, LLC. Pinnacle Conference, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Primary Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Previous Sessions (Available for Viewing)